Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 1
2013 1
2014 3
2015 1
2016 3
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
iPSCs: A powerful tool for skeletal muscle tissue engineering.
Del Carmen Ortuño-Costela M, García-López M, Cerrada V, Gallardo ME. Del Carmen Ortuño-Costela M, et al. Among authors: gallardo me. J Cell Mol Med. 2019 Jun;23(6):3784-3794. doi: 10.1111/jcmm.14292. Epub 2019 Apr 1. J Cell Mol Med. 2019. PMID: 30933431 Free PMC article. Review.
iPSCs-based anti-aging therapies: Recent discoveries and future challenges.
Pareja-Galeano H, Sanchis-Gomar F, Pérez LM, Emanuele E, Lucia A, Gálvez BG, Gallardo ME. Pareja-Galeano H, et al. Among authors: gallardo me. Ageing Res Rev. 2016 May;27:37-41. doi: 10.1016/j.arr.2016.02.007. Epub 2016 Feb 26. Ageing Res Rev. 2016. PMID: 26921478 Review.
Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations.
Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, Gallardo ME, Fernández-Moreno MÁ, Quintanilla M, Garesse R. Cruz-Bermúdez A, et al. Among authors: gallardo me. Oncotarget. 2020 Mar 17;11(11):1006. doi: 10.18632/oncotarget.27522. eCollection 2020 Mar 17. Oncotarget. 2020. PMID: 32215189 Free PMC article.
IPSCs, a Promising Tool to Restore Muscle Atrophy.
Pareja-Galeano H, Sanchis-Gomar F, Emanuele E, Gallardo ME, Lucia A. Pareja-Galeano H, et al. Among authors: gallardo me. J Cell Physiol. 2016 Feb;231(2):259-60. doi: 10.1002/jcp.25114. J Cell Physiol. 2016. PMID: 26224204 Free article.
Enhanced tumorigenicity by mitochondrial DNA mild mutations.
Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, Gallardo ME, Fernández-Moreno MÁ, Quintanilla M, Garesse R. Cruz-Bermúdez A, et al. Among authors: gallardo me. Oncotarget. 2015 May 30;6(15):13628-43. doi: 10.18632/oncotarget.3698. Oncotarget. 2015. PMID: 25909222 Free PMC article.
Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology.
Ortuño-Costela MDC, Cerrada V, Moreno-Izquierdo A, García-Consuegra I, Laberthonnière C, Delourme M, Garesse R, Arenas J, Fuster García C, García García G, Millán JM, Magdinier F, Gallardo ME. Ortuño-Costela MDC, et al. Among authors: gallardo me. Int J Mol Sci. 2022 Nov 12;23(22):13964. doi: 10.3390/ijms232213964. Int J Mol Sci. 2022. PMID: 36430443 Free PMC article.
The pathogenicity scoring system for mitochondrial tRNA mutations revisited.
González-Vioque E, Bornstein B, Gallardo ME, Fernández-Moreno MÁ, Garesse R. González-Vioque E, et al. Among authors: gallardo me. Mol Genet Genomic Med. 2014 Mar;2(2):107-14. doi: 10.1002/mgg3.47. Epub 2013 Nov 11. Mol Genet Genomic Med. 2014. PMID: 24689073 Free PMC article.
13 results